Astrogen Signs $208 Million Autism Drug Supply Deal in Middle East

SEOUL, Jan. 7 (Korea Bizwire) – Astrogen Inc., a South Korean clinical-stage pharmaceutical company, said Wednesday it has signed a US$208.5 million deal with a Middle Eastern company to supply a therapeutic material for treating the core symptoms of autism spectrum disorder (ASD). The partnership with United Arab Emirates-based pharmaceutical distributor Cigalah Medpharm Trading LLC [...]